NOV 26, 2019 1:04 PM PST

Looking into the eyes of MS patients for personalized therapies

WRITTEN BY: Tara Fernandez

Blurred or double vision, and in extreme cases, complete vision loss are amongst the earliest symptoms of multiple sclerosis (MS). In this devastating disease, the body’s own immune system destroys the protective sheath that encases delicate nerve fibers — eventually leading to permanent nerve damage. The degree of symptom severity varies widely amongst MS patients, with very little being known about the genetic factors that influence them.

Johns Hopkins Medicine researchers reported a new way of predicting the progression and intensity of the disease symptoms — by looking into the genes, and the eyes of MS patients. Using this technique, they identified an association between the loss of eyesight and 3 specific genes, from a family of inflammatory proteins known as the complement system.

The study, led by professor of neurology and neuroscience at the Johns Hopkins University School of Medicine, Peter Calabresi, was published in the journal Brain

The researchers used an imaging technology called optical coherence tomography, or OCT, which enables them to take a closer look at the nerve cells in the retinas of patients with MS. They scanned the eyes of these patients periodically from 2010 to 2017, precisely tracking signs of degradation in the back of the eye. Patients were found to lose, on average, a layer of retinal nerve cells about 3 times the width of a human hair every year.

At the same time, DNA from blood samples was extracted and sequenced from these patients to determine whether any genetic factors correlated with diminishing ocular nerve tissue. Screened samples from over 800 MS patients revealed new associations between genetic patterns and a reduction of vision.

Genetic changes in the complement genes C3, C1QA and CR1 were found to be strongly associated with declines in visual clarity. For instance, MS patients with variations in the C1QA complement gene had a 71 percent higher risk of not seeing clearly in low light conditions.

“Complement proteins have traditionally been thought of as part of the immune system, binding to antibodies and helping them kill infected cells in the body,” Calabresi explains, with researchers previously showing that too much complement can wreak havoc on healthy nerves.

Through ongoing studies, the hope is that these developments will enable clinicians to offer more effective, personalized MS treatment programs in the future, customized according to patients’ genetic profiles.

For the 2.3 million living with MS globally, such diagnostic and therapeutic interventions can not come soon enough.


Sources: Johns Hopkins University, Brain.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 05, 2019
Clinical & Molecular DX
NOV 05, 2019
Meningitis and Encephalitis: Testing & Diagnosis Strategies for Effective Treatment
Meningitis is an inflammation of the membranes surrounding the brain (meninges) and spinal cord. Encephalitis, on the other hand, refers to inflammation of...
NOV 20, 2019
Clinical & Molecular DX
NOV 20, 2019
New diagnostic technology seeks out cancer DNA in blood
For many cancers, early detection has a tremendous impact on patient outcomes. Yet, sadly, many of the most common malignancies, like those of the stomach,...
MAR 16, 2020
Clinical & Molecular DX
MAR 16, 2020
New diagnostic tech uses AI to screen blood for over 1400 pathogens
New and reemerging microbial threats continue to challenge the public health and infectious disease response teams worldwide. An estimated 14 million peopl...
MAR 24, 2020
Cardiology
MAR 24, 2020
Infection of The Heart
Inflammation of the heart muscle can affect the hearts electrical system. This can reduce the heart's ability to pump blood or may cause an abnormal he...
MAR 29, 2020
Cancer
MAR 29, 2020
MicroRNA as a New Way to Test for Lung Cancer
The most common, and most deadly, cancer across the world is lung cancer. If caught early, lung cancer has quite a low mortality rate. MicroRNAs may prove to be the answer....
APR 04, 2020
Clinical & Molecular DX
APR 04, 2020
AI Finds New Predictive Markers of Covid-19 Severity
Researchers and healthcare organizations are putting their heads together to consider how technology could ease the ever-worsening COVID-19 global crisis....
Loading Comments...